You’re using a public version of DrugPatentWatch with 1 free search available | Register to unlock more free searches. CREATE FREE ACCOUNT

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
McKesson
Harvard Business School
Baxter
Moodys

Last Updated: February 23, 2024

Investigational Drug Information for Triapine


✉ Email this page to a colleague

« Back to Dashboard


What is the development status for investigational drug Triapine?

Triapine is an investigational drug.

There have been 33 clinical trials for Triapine. The most recent clinical trial was a Phase 2 trial, which was initiated on January 15th 2016.

The most common disease conditions in clinical trials are Adenocarcinoma, Leukemia, and Vaginal Neoplasms. The leading clinical trial sponsors are National Cancer Institute (NCI), Vion Pharmaceuticals, and NRG Oncology.

There are three hundred and eighty-one US patents protecting this investigational drug and four international patents.

Recent Clinical Trials for Triapine
TitleSponsorPhase
Testing the Effectiveness of an Anti-cancer Drug, Triapine, When Used With Targeted Radiation-based Treatment (Lutetium Lu 177 Dotatate), Compared to Lutetium Lu 177 Dotatate Alone for Metastatic Neuroendocrine TumorsNational Cancer Institute (NCI)Phase 2
Testing the Response to the Anti-cancer Drug, Triapine, in Uterine Cancers Using Markers From the Tissue at the Time of HysterectomyNational Cancer Institute (NCI)Early Phase 1
Testing the Addition of an Anti-cancer Drug, Triapine, to the Usual Radiation-Based Treatment (Lutetium Lu 177 Dotatate) for Neuroendocrine TumorsNational Cancer Institute (NCI)Phase 1

See all Triapine clinical trials

Clinical Trial Summary for Triapine

Top disease conditions for Triapine
Top clinical trial sponsors for Triapine

See all Triapine clinical trials

US Patents for Triapine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Triapine ⤷  Try a Trial Methods and compositions for inhibition of Ras ARAXES PHARMA LLC (San Diego, CA) ⤷  Try a Trial
Triapine ⤷  Try a Trial Treatment of solid tumours VIVOLUX AB (Uppsala, SE) ⤷  Try a Trial
Triapine ⤷  Try a Trial Polynucleotides encoding immune modulating polypeptides ModernaTX, Inc. (Cambridge, MA) ⤷  Try a Trial
Triapine ⤷  Try a Trial Substituted imidazo[1,5-a]pyrazines as Btk inhibitors Merck Sharp & Dohme Corp. (Rahway, NJ) ⤷  Try a Trial
Triapine ⤷  Try a Trial Stable formulations of 5,10-methylene-(6R)-tetrahydrofolic acid MERCK & CIE (Schaffhausen, CH) ⤷  Try a Trial
Triapine ⤷  Try a Trial Methods and compositions for treating bacterial infections with iron chelators THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE ARMY (Washington, DC) ⤷  Try a Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Triapine

Drugname Country Document Number Estimated Expiration Related US Patent
Triapine World Intellectual Property Organization (WIPO) WO2016049568 2034-09-25 ⤷  Try a Trial
Triapine Australia AU2012231814 2031-03-21 ⤷  Try a Trial
Triapine Brazil BR112013024211 2031-03-21 ⤷  Try a Trial
Triapine Canada CA2830081 2031-03-21 ⤷  Try a Trial
Triapine China CN103547268 2031-03-21 ⤷  Try a Trial
Triapine Denmark DK2688569 2031-03-21 ⤷  Try a Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
McKesson
Harvard Business School
Baxter
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.